Filing Details

Accession Number:
0001968202-23-000004
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-29 16:07:07
Reporting Period:
2023-03-27
Accepted Time:
2023-03-29 16:07:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585160 E Robert Landry 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Finance Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-27 800 $381.92 32,905 No 4 M Direct
Common Stock Disposition 2023-03-27 589 $825.17 32,316 No 4 F Direct
Common Stock Acquisiton 2023-03-27 3,000 $378.98 35,316 No 4 M Direct
Common Stock Disposition 2023-03-27 2,204 $825.17 33,112 No 4 F Direct
Common Stock Disposition 2023-03-27 39 $819.47 33,073 No 4 S Direct
Common Stock Disposition 2023-03-27 50 $820.46 33,023 No 4 S Direct
Common Stock Disposition 2023-03-27 48 $821.39 32,975 No 4 S Direct
Common Stock Disposition 2023-03-27 18 $822.57 32,957 No 4 S Direct
Common Stock Disposition 2023-03-27 4 $824.30 32,953 No 4 S Direct
Common Stock Disposition 2023-03-27 13 $825.59 32,940 No 4 S Direct
Common Stock Disposition 2023-03-27 4 $829.16 32,936 No 4 S Direct
Common Stock Disposition 2023-03-27 7 $830.01 32,929 No 4 S Direct
Common Stock Disposition 2023-03-28 10 $818.81 32,919 No 4 S Direct
Common Stock Disposition 2023-03-28 115 $820.85 32,804 No 4 S Direct
Common Stock Disposition 2023-03-28 142 $821.40 32,662 No 4 S Direct
Common Stock Disposition 2023-03-28 128 $822.67 32,534 No 4 S Direct
Common Stock Disposition 2023-03-28 181 $823.60 32,353 No 4 S Direct
Common Stock Disposition 2023-03-28 157 $824.54 32,196 No 4 S Direct
Common Stock Disposition 2023-03-28 243 $825.37 31,953 No 4 S Direct
Common Stock Disposition 2023-03-28 31 $826.36 31,922 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2023-03-27 3,000 $0.00 3,000 $378.98
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2023-03-27 800 $0.00 800 $381.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,337 2027-12-12 No 4 M Direct
0 2026-12-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 250 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on February 24, 2023.
  2. Represents volume-weighted average price of sales of 39 shares of Company stock on March 27, 2023 at prices ranging from $819.34 to $819.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
  3. Represents volume-weighted average price of sales of 50 shares of Company stock on March 27, 2023 at prices ranging from $820.00 to $820.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
  4. Represents volume-weighted average price of sales of 48 shares of Company stock on March 27, 2023 at prices ranging from $821.02 to $821.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
  5. Represents volume-weighted average price of sales of 18 shares of Company stock on March 27, 2023 at prices ranging from $822.46 to $822.71. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 27, 2023 at each separate price.
  6. Represents volume-weighted average price of sales of 115 shares of Company stock on March 28, 2023 at prices ranging from $820.67 to $820.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
  7. Represents volume-weighted average price of sales of 142 shares of Company stock on March 28, 2023 at prices ranging from $821.04 to $821.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
  8. Represents volume-weighted average price of sales of 128 shares of Company stock on March 28, 2023 at prices ranging from $822.21 to $822.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
  9. Represents volume-weighted average price of sales of 181 shares of Company stock on March 28, 2023 at prices ranging from $823.02 to $823.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
  10. Represents volume-weighted average price of sales of 157 shares of Company stock on March 28, 2023 at prices ranging from $824.00 to $824.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
  11. Represents volume-weighted average price of sales of 243 shares of Company stock on March 28, 2023 at prices ranging from $825.02 to $825.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on March 28, 2023 at each separate price.
  12. The stock option award vests in four equal annual installments, commencing one year after the date of grant.